AJJ Medtech Holdings Limited (SGX:584)
Singapore · Delayed Price · Currency is SGD 0.0040
-0.0010 (-20.00%)
At close: Aug 14, 2026
AJJ Medtech Holdings Income Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 2.64 | 3.19 | 2.32 | 1.62 | 0.6 | 0.32 |
| 2.64 | 3.19 | 2.32 | 1.62 | 0.6 | 0.32 | |
Revenue Growth | -2.18% | 37.41% | 43.84% | 170.97% | 86.83% | -53.29% |
Cost of Revenue | 1.78 | 2.02 | 1.74 | 0.92 | 0.28 | 0.05 |
Gross Profit | 0.87 | 1.18 | 0.59 | 0.7 | 0.31 | 0.27 |
Selling, General & Admin | 4.22 | 4.11 | 4.55 | 3.27 | 4.28 | 4.37 |
Other Operating Expenses | -0.04 | -0.06 | -0.07 | -0.06 | -0.08 | -0.18 |
Operating Expenses | 4.18 | 4.05 | 4.48 | 3.21 | 4.19 | 4.19 |
Operating Income | -3.31 | -2.87 | -3.89 | -2.51 | -3.88 | -3.92 |
Interest Expense | -0.09 | -0.09 | -0.05 | -0.06 | -0.06 | -0.08 |
EBT Excluding Unusual Items | -3.4 | -2.96 | -3.95 | -2.57 | -3.94 | -3.99 |
Gain (Loss) on Sale of Assets | - | - | - | - | - | 1.88 |
Asset Writedown | - | - | - | - | -0.05 | - |
Legal Settlements | - | - | - | - | - | 0.37 |
Other Unusual Items | 0.03 | 0.03 | 0.08 | 0 | 0.01 | - |
Pretax Income | -3.37 | -2.93 | -3.87 | -2.56 | -3.98 | -1.74 |
Income Tax Expense | 0.01 | 0 | -0 | -0.01 | -0.28 | -0 |
Earnings From Continuing Operations | -3.37 | -2.93 | -3.87 | -2.56 | -3.7 | -1.73 |
Earnings From Discontinued Operations | - | - | - | 0.03 | -0.54 | - |
Net Income to Company | -3.37 | -2.93 | -3.87 | -2.53 | -4.24 | -1.73 |
Minority Interest in Earnings | - | - | - | - | - | 0.04 |
Net Income | -3.37 | -2.93 | -3.87 | -2.53 | -4.24 | -1.7 |
Net Income to Common | -3.37 | -2.93 | -3.87 | -2.53 | -4.24 | -1.7 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,644 | 1,529 | 1,367 | 934 | 934 | 934 |
Shares Outstanding (Diluted) | 1,644 | 1,529 | 1,367 | 934 | 934 | 934 |
Shares Change | 9.32% | 11.89% | 46.39% | - | - | 21.32% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.37 | -1.15 | -1.62 | -1.74 | -3.24 | -6.04 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.01 |
Gross Margin | 32.77% | 36.81% | 25.27% | 43.28% | 52.35% | 84.95% |
Operating Margin | -125.20% | -90.04% | -167.63% | -155.29% | -651.17% | -1228.53% |
Profit Margin | -127.51% | -91.82% | -166.38% | -156.47% | -711.58% | -531.66% |
Free Cash Flow Margin | -51.99% | -36.00% | -69.91% | -107.93% | -543.29% | -1894.67% |
EBITDA | -3.19 | -2.75 | -3.75 | -2.33 | -3.64 | -3.74 |
EBITDA Margin | -120.54% | -86.12% | -161.60% | -144.21% | - | - |
D&A For EBITDA | 0.12 | 0.13 | 0.14 | 0.18 | 0.24 | 0.18 |
EBIT | -3.31 | -2.87 | -3.89 | -2.51 | -3.88 | -3.92 |
EBIT Margin | -125.20% | -90.04% | -167.63% | -155.29% | - | - |